OBJECTIVE:
The purpose of this video is to demonstrate a novel technique for surgical management of uterovaginal prolapse that reduces operating time and minimizes the advanced suturing skills typically involved with the traditional method. It leverages the experience with the Shirodkar cerclage with sacral fixation in order to perform sacrohysteropexy. Laparoscopic cerclage sacrohysteropexy differs from traditional sacrocolpopexy in that absolutely no endoscopic suturing of the mesh onto the vagina or cervix is required. DESCRIPTION: The procedure is begun laparoscopically, where the peritoneum overlying the sacral promontory is incised and dissection is performed to expose the anterior longitudinal ligament of the sacrum. The incision is continued along the right pelvic sidewall, lateral to the rectum and medial to the right ureter, and the rectovaginal space is dissected allowing the rectum to be displaced posteriorly. The surgery is continued vaginally, where an incision is made at the cervico-vaginal junction from 10:00 o'clock to 2:00 o'clock and the bladder is advanced off the cervix. A posterior incision is then made between 4:00 o'clock to 8:00 o'clock, and the posterior cul-de-sac is entered. An Emmett needle is passed bilaterally from the posterior to anterior cervix and a polypropylene mesh sling is drawn through the lateral cervix and placed flat anteriorly on the cervix. The two tails existing posteriorly are sutured side-by-side and this sacral extension is placed into the pelvis through the cul-de-sac incision. The two vaginal incisions are closed with absorbable suture. Laparoscopically, the mesh is fixed to the sacrum (S1) with permanent sutures and the peritoneum is closed over the mesh. CONCLUSION: The steps shown for placement of a cervical mesh are familiar and easily reproducible, and can greatly simplify what is classically a complex surgical procedure.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS:
Christina Salazar: Nothing to disclose; Peter L. Rosenblatt: Boston Scientific, consultant, consulting fee; Coloplast, consultant, consulting fee; Medtronic, consultant, consulting fee.
14 Advances in ablative and non-ablative lasers in gynecology: A clinician's guide Departments of OB/GYN and Urology, Georgetown University School of Medicine, Washington, DC OBJECTIVE: The purpose of this educational video is to describe the biophysics of fractional ablative and non-ablative lasers used in gynecology including a procedural demonstration. DESCRIPTION: Laser technology is a relatively new tool for gynecology. The first laser was invented in the 1960s and by 2000, low energy minimally invasive lasers were used in dermatology. In the last three years, dozens of laser manufactures have started marketing fractional ablative and non-ablative technology for office based procedures. Non-ablative and fractional techniques have revolutionized the field of skin rejuvenation and resurfacing by providing dermal focused therapy at low energy levels. The low energy levels improve patient tolerance and decrease downtime. This technology has been used in conditions such as atrophic vaginitis, vaginal laxity, lichen sclerosus, and stress urinary incontinence. The American College of Obstetricians and Gynecologist issued a statement about fractional laser treatments in 2016. The FDA has only cleared, but not approved, this surgical technology. The clearance does not describe any disease or pathologies approved for treatment. Most of the research is observational and short term at this time. There are current trials in place focusing on comparative treatment options and long term data to fill this research void. CONCLUSION: This video will provide an introduction for gynecologic surgeons on the basic science and biophysics of laser technology and a summary of available outcome data for vaginal and vulvar conditions.
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15 The sinistral surgeon: How to teach the left-hand dominant gynecology trainee
S. Son, T. Muffly
Department of Obstetrics and Gynecology, Denver Health and Hospital Authority, Denver, CO OBJECTIVE: The purpose of this Video Presentation is to demonstrate how to avoid the five most common difficulties of the left-handed trainee. DESCRIPTION: Handedness is a faster or more precise performance or individual preference for use of a hand. Handedness is not a discrete variable (right or left), but a continuous one that can be expressed at levels between strong left and strong right. There are several types of handedness: left-handedness, right-handedness, and ambidexterity. Eleven percent of Americans (20% of men and 8% of women) are left-handed. Studies reflect similar percentages of lefthanders among medical personnel. Left-handedness has been considered a simple inconvenience by some, whereas some left-handed gynecologists feel that they are "the last unorganized minority." There are a number of ways that a left-handed surgeon can overcome this right-handed bias. There are a number of ways that a left-handed surgeon can overcome this right-handed bias. We describe five techniques. CONCLUSION: Left-handed individuals comprise a minority of gynecologic surgeons and trainees. Though many such individuals develop varying degrees of ambidexterity with experience, preferential use of their dominant hand is inevitable. Despite the hands-on nature of the gynecologist's practice both in and out of the OR, tailored instruction for those with left-hand dominance is uncommon. Consequences, if any, of this missing training are unknown as left-handed gynecologists seem to adapt to environments biased to right-handed surgeons. Comparative studies are necessary to determine differences in performance, skill, and outcomes that may exist between left-handed gynecologists and their right-handed counterparts.
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Shannon Son: Nothing to disclose; Tyler Muffly: Nothing to disclose. She denied pain but reported a vaginal mass that she had been unable to manually reduce for the past 5 days. She was transferred from another institution with a computed tomography (CT) scan demonstrating a 6 to 7-cm mass protruding through the vaginal epithelium which was concerning for mesenteric evisceration. The patient was managed through a combined laparoscopic and vaginal approach. Eviscerated epiploica from the sigmoid colon was identified and reduced vaginally. Three segments of non-viable epiploica were then excised laparoscopically and proctoscopy was performed to evaluate possible injury or involvement of the distal sigmoid colon. A Mayo McCall uterosacral culdoplasty was performed to decrease pressure on the repaired vaginal defect by resuspending the vaginal apex and reinforcing the closure, in an attempt to prevent short-term evisceration recurrence. The patient's total vaginal length at the completion of the case was 7-8 cm. CONCLUSION: A combined laparoscopic and vaginal repair of a vaginal cuff dehiscence was performed. It is important to perform concomitant intra-abdominal evaluation at the time of evisceration repair to rule out bowel necrosis, with the potential assistance of a general or colorectal surgeon. Performing a concomitant Mayo McCall culdoplasty may theoretically prevent recurrent evisceration in the setting of vaginal prolapse.
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